Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Novartis325 enrolled

Overview

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

325

Conditions

Mixed Dyslipidemia Hypercholesterolemia

Interventions

FluvastatinDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Mixed dyslipidemia * Primary hypercholesterolemia Exclusion Criteria: * Pregnant or lactating women * Age \> 18 years Other protocol-defined inclusion and exclusion criteria may apply.

Locations (1)

Novartis

Shanghai, China

Outcomes

Primary Outcomes

Percent change from baseline in low density lipoprotein cholesterol after 12 weeks

Secondary Outcomes

Percent change from baseline in total cholesterol after 12 weeks

Percent change from baseline in high density lipoprotein cholesterol after 12 weeks

Percent change from baseline in total triglycerides after 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.